Total Payments
$46,375
2024 Payments
$10,110
Companies
48
Transactions
1,082
Medicare Patients
7,880
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$25,736 (55.5%)
Other$20,040 (43.2%)
Travel$400.00 (0.9%)
Gifts$100.00 (0.2%)
Education$99.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $25,736 | 1,062 | 55.5% |
| Honoraria | $10,500 | 5 | 22.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,540 | 11 | 20.6% |
| Travel and Lodging | $400.00 | 2 | 0.9% |
| Gift | $100.00 | 1 | 0.2% |
| Education | $99.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intra-Sana Laboratories | $13,042 | 36 | $0 (2024) |
| RedHill Biopharma Inc. | $8,158 | 42 | $0 (2024) |
| ABBVIE INC. | $3,891 | 157 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $3,455 | 209 | $0 (2024) |
| Allergan, Inc. | $2,886 | 32 | $0 (2020) |
| QOL Medical, LLC | $1,950 | 94 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $1,378 | 54 | $0 (2023) |
| IRONWOOD PHARMACEUTICALS, INC | $1,200 | 48 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,158 | 59 | $0 (2023) |
| Janssen Biotech, Inc. | $1,087 | 42 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,110 | 171 | Intra-Sana Laboratories ($5,947) |
| 2023 | $9,415 | 154 | Intra-Sana Laboratories ($6,437) |
| 2022 | $6,064 | 152 | RedHill Biopharma Inc. ($2,449) |
| 2021 | $8,294 | 168 | RedHill Biopharma Inc. ($5,420) |
| 2020 | $2,226 | 113 | AbbVie Inc. ($406.35) |
| 2019 | $2,732 | 137 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($639.26) |
| 2018 | $3,016 | 106 | AbbVie, Inc. ($672.21) |
| 2017 | $4,517 | 81 | Allergan Inc. ($2,242) |
All Payment Transactions
1,082 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $20.69 | General |
| Category: GI | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $35.06 | General |
| Category: LIVER DISEASE | ||||||
| 12/16/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: GALLSTONES | ||||||
| 12/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.41 | General |
| 12/06/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/04/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $137.07 | General |
| Category: LIVER DISEASE | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | Enterra Medical, Inc. | — | Food and Beverage | In-kind items and services | $15.66 | General |
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $32.32 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/26/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $105.47 | General |
| Category: Obesity | ||||||
| 11/21/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $33.98 | General |
| Category: Immunology | ||||||
| 11/20/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $34.45 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.79 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: IMMUNOLOGY | ||||||
| 11/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Intra-Sana Laboratories | — | Honoraria | Cash or cash equivalent | $2,500.00 | General |
| 11/13/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $128.58 | General |
| Category: GALLSTONES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,114 | 3,015 | $909,553 | $391,308 |
| 2022 | 23 | 2,599 | 3,906 | $1.1M | $446,902 |
| 2021 | 17 | 1,989 | 2,744 | $647,026 | $317,549 |
| 2020 | 16 | 1,178 | 2,030 | $470,349 | $201,531 |
Total Patients
7,880
Total Services
11,695
Medicare Billing
$1.4M
Procedure Codes
84
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 331 | 636 | $147,558 | $103,687 | 70.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 240 | 612 | $190,737 | $44,217 | 23.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 110 | 110 | $85,873 | $41,905 | 48.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 241 | 258 | $94,364 | $40,826 | 43.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 90 | 95 | $79,128 | $32,658 | 41.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 149 | 149 | $48,094 | $29,845 | 62.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 126 | 189 | $53,089 | $20,531 | 38.7% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 258 | 278 | $45,588 | $19,043 | 41.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 100 | $24,891 | $11,614 | 46.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2023 | 34 | 34 | $22,273 | $10,583 | 47.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 25 | 46 | $19,478 | $9,051 | 46.5% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 182 | 209 | $19,326 | $6,396 | 33.1% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 69 | 78 | $5,925 | $3,922 | 66.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 37 | 39 | $25,638 | $3,125 | 12.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 20 | 21 | $15,082 | $2,982 | 19.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 24 | 37 | $6,937 | $2,967 | 42.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 14 | 14 | $12,234 | $2,908 | 23.8% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Office | 2023 | 11 | 11 | $8,610 | $2,669 | 31.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 69 | 79 | $2,724 | $1,720 | 63.1% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 19 | 20 | $2,004 | $659.38 | 32.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 354 | 1,056 | $316,200 | $69,820 | 22.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 194 | 344 | $79,066 | $58,043 | 73.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 277 | 295 | $115,018 | $54,379 | 47.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 97 | 98 | $77,420 | $35,604 | 46.0% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 415 | 482 | $84,350 | $34,689 | 41.1% |
About Dr. Kostas Sideridis, DO
Dr. Kostas Sideridis, DO is a Gastroenterology healthcare provider based in Syosset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003913682.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kostas Sideridis, DO has received a total of $46,375 in payments from pharmaceutical and medical device companies, with $10,110 received in 2024. These payments were reported across 1,082 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($25,736).
As a Medicare-enrolled provider, Sideridis has provided services to 7,880 Medicare beneficiaries, totaling 11,695 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Syosset, NY
- Active Since 09/17/2006
- Last Updated 06/02/2009
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003913682
Products in Payments
- RELTONE 200 MG (Drug) $8,042
- Talicia (Drug) $7,860
- XIFAXAN (Drug) $3,287
- LINZESS (Drug) $2,530
- ZENPEP (Drug) $1,511
- Linzess (Drug) $1,200
- Sucraid (Drug) $1,127
- Humira (Biological) $935.60
- STELARA (Biological) $867.58
- SUCRAID (Drug) $823.13
- TRULANCE (Drug) $718.89
- DUPIXENT (Biological) $689.42
- ENTYVIO (Biological) $635.78
- IBSRELA (Drug) $616.83
- VIBERZI (Drug) $590.27
- HUMIRA (Biological) $499.90
- SKYRIZI (Biological) $462.01
- ZEPOSIA (Drug) $434.44
- RINVOQ (Biological) $362.82
- Mavyret (Drug) $320.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Syosset
Dr. Jaydeep Kadam, M.d, M.D
Gastroenterology — Payments: $34,570
Gastroenterology $34,570
Sandra Layne, M.d, M.D
Gastroenterology — Payments: $10,841
Gastroenterology $10,841
Dr. Soren Gandhi, M.d, M.D
Gastroenterology — Payments: $8,313
Gastroenterology $8,313
Dr. Faisal Sheikh, D.o, D.O
Gastroenterology — Payments: $6,261
Gastroenterology $6,261
Arthur Lowy, M.d, M.D
Gastroenterology — Payments: $4,274
Gastroenterology $4,274
Joseph Lazar, Md, MD
Gastroenterology — Payments: $555.80
Gastroenterology $555.80